GLP-1 drugs: what HUSKY Health paid

Q: Does a paid prescription mean HUSKY Health covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

HUSKY Health shows a published payment figure for 7 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read HUSKY Health's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What HUSKY Health’s payment record shows

In 2026Q1, the product HUSKY Health paid for most often was Ozempic®, at 16,457 prescriptions¹⁹ of the 33,077 to 33,149^{1,7,13,19,25,37,43} across all 8 products, or 50 percent of the published count.

HUSKY Health itself reimbursed at least $41,165,056 for these products in the quarter, about $1,245 per prescription. Pharmacies were paid $41,928,051 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Rybelsus®, at about $1,651.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what HUSKY Health finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, HUSKY Health. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What HUSKY Health paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what HUSKY Health paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Fee-for-service	3,828¹	12%	$4,344,895	$4,362,485	$1,135
tirzepatideMounjaro®	Fee-for-service	11,118⁷	34%	$14,311,855	$14,638,978	$1,287
semaglutideWegovy®	Fee-for-service	at least 1,127¹³	3%	$1,342,389	$1,522,667	$1,191
semaglutideOzempic®	Fee-for-service	16,457¹⁹	50%	$20,328,914	$20,557,757	$1,235
semaglutideRybelsus®	Fee-for-service	483²⁵	1%	$797,514	$806,676	$1,651
liraglutideSaxenda®	Not published	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Fee-for-service	40³⁷	<1%	$34,407	$34,407	$860
liraglutideliraglutide (generic)	Fee-for-service	at least 16⁴³	<1%	$5,081	$5,081	$318

Every published claim in this record came through fee-for-service, meaning the program paid the pharmacy directly. This record shows no managed-care claims for these products. That is a fact about how the file reports, and it points at who to ask: the program.

Across the 21 quarters on file, prescriptions for the products published at both ends of the series were lower in 2026Q1 than in 2021Q1: 523 against 3,357. Products whose count was withheld at either end are left out of that comparison, because a floor against a number cannot establish a direction.

Against enrollment, that is 37.6 to 37.7 prescriptions per thousand people enrolled in HUSKY Health, on an average of 879,065 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 3 of the 168 product-quarters it holds a row for here, which is 2 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic®, Rybelsus® and Victoza® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether HUSKY Health pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what HUSKY Health paid for each product, quarter by quarter

Prescriptions HUSKY Health paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®range 11 to 3,828	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³No row	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³Withheld1 of 1 product codes withheld	11 paid prescriptions in the quarter (2024Q4)³Count$11,361 paid	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter²No row	834 paid prescriptions in the quarter (2025Q3)²Count$921,911 paid	at least 2,516 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$2,804,850 paid	3,828 paid prescriptions in the quarter (2026Q1)¹Count$4,344,895 paid
tirzepatideMounjaro®range 1,100 to 13,416, down 560 on the quarter before	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹¹Withheld2 of 2 product codes withheld	at least 278 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld¹¹At least$304,897 paid	1,100 paid prescriptions in the quarter (2022Q4)¹¹Count$1,135,172 paid	2,420 paid prescriptions in the quarter (2023Q1)¹⁰Count$2,565,609 paid	3,967 paid prescriptions in the quarter (2023Q2)¹⁰Count$4,290,443 paid	5,404 paid prescriptions in the quarter (2023Q3)¹⁰Count$5,947,705 paid	7,000 paid prescriptions in the quarter (2023Q4)¹⁰Count$7,773,508 paid	8,190 paid prescriptions in the quarter (2024Q1)⁹Count$9,442,556 paid	9,296 paid prescriptions in the quarter (2024Q2)⁹Count$10,609,934 paid	11,770 paid prescriptions in the quarter (2024Q3)⁹Count$13,473,837 paid	13,416 paid prescriptions in the quarter (2024Q4)⁹Count$15,476,903 paid	12,908 paid prescriptions in the quarter (2025Q1)⁸Count$14,655,594 paid	13,368 paid prescriptions in the quarter (2025Q2)⁸Count$15,625,666 paid	12,373 paid prescriptions in the quarter (2025Q3)⁸Count$14,899,245 paid	11,678 paid prescriptions in the quarter (2025Q4)⁸Count$14,490,585 paid	11,118 paid prescriptions in the quarter (2026Q1)⁷Count$14,311,855 paid
semaglutideWegovy®range 453 to 927	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	at least 16 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld¹⁸At least$25,129 paid	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter¹⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter¹⁵No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter¹⁵No row	at least 14 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$18,362 paid	at least 85 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$83,702 paid	453 paid prescriptions in the quarter (2025Q2)¹⁴Count$509,079 paid	660 paid prescriptions in the quarter (2025Q3)¹⁴Count$765,744 paid	927 paid prescriptions in the quarter (2025Q4)¹⁴Count$1,114,048 paid	at least 1,127 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$1,342,389 paid
semaglutideOzempic®range 4,538 to 38,892, up 205 on the quarter before	at least 4,529 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$5,296,831 paid	4,802 paid prescriptions in the quarter (2021Q2)²⁴Count$5,694,882 paid	4,538 paid prescriptions in the quarter (2021Q3)²⁴Count$5,329,528 paid	4,922 paid prescriptions in the quarter (2021Q4)²⁴Count$5,917,126 paid	6,025 paid prescriptions in the quarter (2022Q1)²³Count$7,400,042 paid	7,521 paid prescriptions in the quarter (2022Q2)²³Count$9,255,792 paid	10,563 paid prescriptions in the quarter (2022Q3)²³Count$12,467,609 paid	12,051 paid prescriptions in the quarter (2022Q4)²³Count$13,993,893 paid	16,214 paid prescriptions in the quarter (2023Q1)²²Count$18,714,525 paid	at least 22,829 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$25,955,867 paid	at least 26,288 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$29,763,471 paid	at least 26,152 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²²At least$29,648,240 paid	at least 30,331 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$35,337,048 paid	at least 36,615 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²¹At least$42,458,741 paid	at least 39,401 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²¹At least$45,595,928 paid	38,892 paid prescriptions in the quarter (2024Q4)²¹Count$44,175,093 paid	32,857 paid prescriptions in the quarter (2025Q1)²⁰Count$35,153,214 paid	at least 30,256 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$33,351,359 paid	at least 22,488 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$25,665,358 paid	16,252 paid prescriptions in the quarter (2025Q4)²⁰Count$19,489,223 paid	16,457 paid prescriptions in the quarter (2026Q1)¹⁹Count$20,328,914 paid
semaglutideRybelsus®range 436 to 1,068, down 99 on the quarter before	436 paid prescriptions in the quarter (2021Q1)³⁰Count$472,397 paid	493 paid prescriptions in the quarter (2021Q2)³⁰Count$578,025 paid	617 paid prescriptions in the quarter (2021Q3)³⁰Count$706,448 paid	570 paid prescriptions in the quarter (2021Q4)³⁰Count$662,329 paid	699 paid prescriptions in the quarter (2022Q1)²⁹Count$879,847 paid	789 paid prescriptions in the quarter (2022Q2)²⁹Count$922,335 paid	at least 899 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$1,072,190 paid	at least 901 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$1,107,531 paid	at least 1,094 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$1,373,720 paid	at least 1,140 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$1,505,005 paid	at least 1,047 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$1,406,351 paid	at least 1,015 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$1,396,712 paid	at least 993 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$1,410,002 paid	1,068 paid prescriptions in the quarter (2024Q2)²⁷Count$1,507,011 paid	at least 1,026 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$1,468,931 paid	at least 1,016 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$1,376,556 paid	at least 941 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$1,253,159 paid	844 paid prescriptions in the quarter (2025Q2)²⁶Count$1,167,388 paid	716 paid prescriptions in the quarter (2025Q3)²⁶Count$1,050,505 paid	582 paid prescriptions in the quarter (2025Q4)²⁶Count$924,031 paid	483 paid prescriptions in the quarter (2026Q1)²⁵Count$797,514 paid
liraglutideSaxenda®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³³Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2025Q1)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 40 to 2,921, down 15 on the quarter before	2,921 paid prescriptions in the quarter (2021Q1)⁴²Count$3,427,766 paid	2,339 paid prescriptions in the quarter (2021Q2)⁴²Count$2,780,748 paid	2,601 paid prescriptions in the quarter (2021Q3)⁴²Count$3,127,705 paid	2,111 paid prescriptions in the quarter (2021Q4)⁴²Count$2,537,532 paid	2,190 paid prescriptions in the quarter (2022Q1)⁴¹Count$2,725,084 paid	2,071 paid prescriptions in the quarter (2022Q2)⁴¹Count$2,552,192 paid	2,045 paid prescriptions in the quarter (2022Q3)⁴¹Count$2,505,159 paid	1,753 paid prescriptions in the quarter (2022Q4)⁴¹Count$2,120,870 paid	1,745 paid prescriptions in the quarter (2023Q1)⁴⁰Count$2,098,079 paid	1,491 paid prescriptions in the quarter (2023Q2)⁴⁰Count$1,862,636 paid	1,109 paid prescriptions in the quarter (2023Q3)⁴⁰Count$1,343,973 paid	892 paid prescriptions in the quarter (2023Q4)⁴⁰Count$1,076,512 paid	774 paid prescriptions in the quarter (2024Q1)³⁹Count$727,161 paid	632 paid prescriptions in the quarter (2024Q2)³⁹Count$528,947 paid	395 paid prescriptions in the quarter (2024Q3)³⁹Count$329,765 paid	314 paid prescriptions in the quarter (2024Q4)³⁹Count$277,932 paid	171 paid prescriptions in the quarter (2025Q1)³⁸Count$123,718 paid	74 paid prescriptions in the quarter (2025Q2)³⁸Count$56,915 paid	56 paid prescriptions in the quarter (2025Q3)³⁸Count$44,179 paid	55 paid prescriptions in the quarter (2025Q4)³⁸Count$47,608 paid	40 paid prescriptions in the quarter (2026Q1)³⁷Count$34,407 paid
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter⁴⁵No row	at least 24 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$19,248 paid	at least 15 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$9,563 paid	at least 104 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$56,670 paid	at least 68 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$38,407 paid	at least 49 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$23,772 paid	at least 28 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$14,121 paid	at least 16 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$5,081 paid

What this page cannot tell you

Whether HUSKY Health covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Connecticut in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, CT
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state CT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "1350"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, CT
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state CT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "1099"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, CT
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state CT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "11"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, CT
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state CT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like ZEPBOUND%, state CT, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, CT
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state CT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like ZEPBOUND%, state CT, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, CT
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state CT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like ZEPBOUND%, state CT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, CT
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state CT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "2409"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, CT
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state CT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "2852"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, CT
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state CT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "3189"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, CT
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state CT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2023", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "1921"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, CT
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state CT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "438"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, CT
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state CT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like MOUNJARO%, state CT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, CT
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state CT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "347"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, CT
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state CT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2025", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "265"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, CT
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state CT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "14"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, CT
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state CT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like WEGOVY%, state CT, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, CT
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state CT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like WEGOVY%, state CT, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, CT
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state CT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2021", "quarter": "3", "utilization_type": "FFSU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "16"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, CT
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state CT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "6068"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, CT
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state CT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2025", "quarter": "2", "utilization_type": "FFSU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "11171"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, CT
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state CT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "16623"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, CT
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state CT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2023", "quarter": "3", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "12899"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, CT
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state CT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2022", "quarter": "4", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "6572"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, CT
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state CT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2021", "quarter": "2", "utilization_type": "FFSU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "2832"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, CT
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state CT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "203"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, CT
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state CT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "353"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, CT
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state CT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2024", "quarter": "2", "utilization_type": "FFSU", "product_name": "RYBELSUS 3", "suppression_used": "false", "number_of_prescriptions": "367"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, CT
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state CT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2023", "quarter": "2", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "455"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, CT
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state CT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2022", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "396"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, CT
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state CT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2021", "quarter": "3", "utilization_type": "FFSU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "277"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, CT
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state CT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like SAXENDA%, state CT, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, CT
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state CT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like SAXENDA%, state CT, 2025", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, CT
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state CT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2024", "quarter": "4", "utilization_type": "FFSU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, CT
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state CT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like SAXENDA%, state CT, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, CT
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state CT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like SAXENDA%, state CT, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, CT
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state CT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like SAXENDA%, state CT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, CT
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state CT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "23"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, CT
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state CT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "97"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, CT
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state CT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2024", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "455"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, CT
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state CT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2023", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "1008"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, CT
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state CT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2022", "quarter": "1", "utilization_type": "FFSU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "1331"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, CT
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state CT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2021", "quarter": "1", "utilization_type": "FFSU", "product_name": "Victoza 6M", "suppression_used": "false", "number_of_prescriptions": "1794"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, CT
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state CT, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "CT", "year": "2026", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "16"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, CT
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state CT, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2025", "quarter": "1", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "68"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, CT
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state CT, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "year": "2024", "quarter": "3", "utilization_type": "FFSU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "24"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, CT
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state CT, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like LIRAGLUTID%, state CT, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, CT
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state CT, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like LIRAGLUTID%, state CT, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, CT
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state CT, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "CT", "product_name": "product_name like LIRAGLUTID%, state CT, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 34 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 14 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean HUSKY Health covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.